Cystex Tablet
Product Images NDC 69693-513

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cystex (NDC 69693-513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clarion Brands, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Pack (Blister)

Text panel for Cystex urinary pain relief tablets containing methenamine 162 mg and sodium salicylate 162.5 mg (NSAID). Includes warnings about Reye's syndrome, stomach bleeding, and precautions for certain medical conditions and medications. Advises to use tablets only if blister seals are unbroken and shows lot and expiration date placeholders with a contact number for CYSTEX, LLC.*

FDA Label Image

Carton (Carton)

Packaging label for Cystex Max Strength UTI Pain Relief tablets containing methenamine 162 mg and sodium salicylate 162.5 mg. The label highlights fast relief of pain and burning plus bacteria control for UTI. It contains 48 tablets and is produced by Clarion Brands, LLC. The drug facts panel includes active ingredients and additional directions and warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.